PATENT CLAIM ANALYSIS

Application Number: 16074429
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "093210"]

Abstract:
The invention provides a cellular immunotherapy therapy product comprising CAR T cells that are enriched in CD8+ cells. Also provided are methods for making and using the product.

Claim (Index 24):
The method of  claim 22 , wherein the step of purifying comprises positive selection.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14389677', '15965739', '15965738', '14805193', '16050754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7457698494402206
- 35 USC 102 Novelty (BERT): 0.5319618487657648
- Combined Prediction Score: 0.724389049372775
- Mean Citation Score: 334.43033
- Max Citation Score: 346.75323
- Similarity Product: 224.14086577973129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test